de Prudential Financial Ligand Pharmaceuticals LGND Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 17.3 M | Vender |
54,623
-9,510
| -15% | -USD 2.24 M | 0.02% | 482 |
|
|
2026
Q1 | USD 12.8 M | Comprar |
64,133
+18,497
| +41% | +USD 3.66 M | 0.02% | 530 |
|
|
2025
Q4 | USD 8.63 M | Comprar |
45,636
+16,609
| +57% | +USD 3.19 M | 0.01% | 677 |
|
|
2025
Q3 | USD 5.14 M | Comprar |
29,027
+660
| +2% | +USD 98.1 k | 0.01% | 930 |
|
|
2025
Q2 | USD 3.22 M | Vender |
28,367
-12,588
| -31% | -USD 1.35 M | ﹤0.01% | 1142 |
|
|
2025
Q1 | USD 4.31 M | Vender |
40,955
-62,040
| -60% | -USD 7.02 M | 0.01% | 911 |
|
|
2024
Q4 | USD 11 M | Comprar |
102,995
+1,360
| +1% | +USD 154 k | 0.02% | 569 |
|
|
2024
Q3 | USD 10.2 M | Comprar |
101,635
+83,715
| +467% | +USD 8.43 M | 0.01% | 677 |
|
|
2024
Q2 | USD 1.51 M | Vender |
17,920
-14,865
| -45% | -USD 1.18 M | ﹤0.01% | 1588 |
|
|
2024
Q1 | USD 2.4 M | Comprar |
32,785
+13,830
| +73% | +USD 1.02 M | ﹤0.01% | 1340 |
|
|
2023
Q4 | USD 1.35 M | Vender |
18,955
-52,407
| -73% | -USD 3.09 M | ﹤0.01% | 1662 |
|
|
2023
Q3 | USD 4.28 M | Vender |
71,362
-5,470
| -7% | -USD 360 k | 0.01% | 966 |
|
|
2023
Q2 | USD 5.54 M | Comprar |
76,832
+61,261
| +393% | +USD 4.6 M | 0.01% | 855 |
|
|
2023
Q1 | USD 1.15 M | Vender |
15,571
-2,750
| -15% | -USD 195 k | ﹤0.01% | 1674 |
|
|
2022
Q4 | USD 1.22 M | Vender |
18,321
-7,842
| -30% | -USD 510 k | ﹤0.01% | 1605 |
|
|
2022
Q3 | USD 1.4 M | Vender |
26,163
-1,290
| -5% | -USD 75.8 k | ﹤0.01% | 1551 |
|
|
2022
Q2 | USD 1.53 M | Vender |
27,453
-431
| -2% | -USD 24.5 k | ﹤0.01% | 1555 |
|
|
2022
Q1 | USD 1.96 M | Vender |
27,884
-465
| -2% | -USD 33.7 k | ﹤0.01% | 1505 |
|
|
2021
Q4 | USD 2.78 M | Vender |
28,349
-545
| -2% | -USD 50.3 k | ﹤0.01% | 1351 |
|
|
2021
Q3 | USD 2.61 M | Comprar |
28,894
+9,727
| +51% | +USD 752 k | ﹤0.01% | 1321 |
|
|
2021
Q2 | USD 1.57 M | Vender |
19,167
-21,475
| -53% | -USD 1.79 M | ﹤0.01% | 1595 |
|
|
2021
Q1 | USD 3.86 M | Vender |
40,642
-117,257
| -74% | -USD 11.1 M | 0.01% | 1138 |
|
|
2020
Q4 | USD 9.8 M | Comprar |
157,899
+6,098
| +4% | +USD 348 k | 0.02% | 750 |
|
|
2020
Q3 | USD 9.03 M | Comprar |
151,801
+80,155
| +112% | +USD 5.47 M | 0.02% | 699 |
|
|
2020
Q2 | USD 5 M | Comprar |
71,646
+51,249
| +251% | +USD 3.25 M | 0.01% | 955 |
|
|
2020
Q1 | USD 925 k | Vender |
20,397
-1,784
| -8% | -USD 101 k | ﹤0.01% | 1718 |
|
|
2019
Q4 | USD 1.44 M | Vender |
22,181
-9,600
| -30% | -USD 642 k | ﹤0.01% | 1735 |
|
|
2019
Q3 | USD 1.97 M | Vender |
31,781
-901
| -3% | -USD 56.6 k | ﹤0.01% | 1587 |
|
|
2019
Q2 | USD 2.33 M | Vender |
32,682
-784
| -2% | -USD 57.7 k | ﹤0.01% | 1520 |
|
|
2019
Q1 | USD 2.62 M | Vender |
33,466
-877
| -3% | -USD 66.4 k | ﹤0.01% | 1460 |
|
|
2018
Q4 | USD 2.91 M | Vender |
34,343
-136,979
| -80% | -USD 14.6 M | 0.01% | 1335 |
|
|
2018
Q3 | USD 29.3 M | Comprar |
171,322
+44,820
| +35% | +USD 6.76 M | 0.04% | 475 |
|
|
2018
Q2 | USD 16.3 M | Comprar |
126,502
+2,029
| +2% | +USD 226 k | 0.02% | 727 |
|
|
2018
Q1 | USD 12.8 M | Vender |
124,473
-1,980
| -2% | -USD 196 k | 0.02% | 797 |
|
|
2017
Q4 | USD 10.8 M | Comprar |
126,453
+10,797
| +9% | +USD 936 k | 0.01% | 884 |
|
|
2017
Q3 | USD 9.8 M | Comprar |
115,656
+37,899
| +49% | +USD 3 M | 0.01% | 897 |
|
|
2017
Q2 | USD 5.89 M | Vender |
77,757
-17,886
| -19% | -USD 1.25 M | 0.01% | 1072 |
|
|
2017
Q1 | USD 6.32 M | Vender |
95,643
-11,354
| -11% | -USD 747 k | 0.01% | 1023 |
|
|
2016
Q4 | USD 6.78 M | Vender |
106,997
-10,743
| -9% | -USD 678 k | 0.01% | 991 |
|
|
2016
Q3 | USD 7.5 M | Vender |
117,740
-32,782
| -22% | -USD 2.41 M | 0.01% | 934 |
|
|
2016
Q2 | USD 11.2 M | Comprar |
150,522
+10,745
| +8% | +USD 797 k | 0.02% | 774 |
|
|
2016
Q1 | USD 9.34 M | Comprar |
139,777
+4,433
| +3% | +USD 269 k | 0.02% | 835 |
|
|
2015
Q4 | USD 9.15 M | Vender |
135,344
-15,598
| -10% | -USD 963 k | 0.02% | 828 |
|
|
2015
Q3 | USD 8.06 M | Vender |
150,942
-11,012
| -7% | -USD 668 k | 0.02% | 823 |
|
|
2015
Q2 | USD 10.2 M | Vender |
161,954
-31,515
| -16% | -USD 1.72 M | 0.02% | 810 |
|
|
2015
Q1 | USD 9.31 M | Vender |
193,469
-119,199
| -38% | -USD 4.57 M | 0.02% | 857 |
|
|
2014
Q4 | USD 10.4 M | Vender |
312,668
-114,134
| -27% | -USD 3.71 M | 0.02% | 707 |
|
|
2014
Q3 | USD 12.5 M | Comprar |
426,802
+40,357
| +10% | +USD 1.34 M | 0.02% | 626 |
|
|
2014
Q2 | USD 15 M | Comprar |
386,445
+15,732
| +4% | +USD 638 k | 0.03% | 595 |
|
|
2014
Q1 | USD 15.6 M | Vender |
370,713
-57,548
| -13% | -USD 2.4 M | 0.03% | 557 |
|
|
2013
Q4 | USD 14.1 M | Comprar |
428,261
+140,840
| +49% | +USD 4.59 M | 0.03% | 580 |
|
|
2013
Q3 | USD 7.76 M | Comprar |
287,421
+62,998
| +28% | +USD 1.77 M | 0.02% | 760 |
|
|
2013
Q2 | USD 5.24 M | Comprar |
+224,423
| Nuevas | +USD 4.04 M | 0.01% | 880 |
|
Otros fondos que tienen LGND en su cartera
Posición de Prudential Financial en LGND: resumen de T2 2026
Prudential Financial redujo su participación en Ligand Pharmaceuticals (LGND) en 15% durante T2 2026, al vender acciones por un valor estimado de USD 2.24 M, y conservó 54,623 acciones valuadas en USD 17.3 M. La posición representa 0.02% de la cartera y ocupa el puesto #482.
Prudential Financial reportó por primera vez una posición en LGND en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 29.3 M en T3 2018. Al cierre de T2 2026, 418 fondos que sigue Wall St. Rank mantienen una posición en LGND.
- Al cierre de T2 2026, Prudential Financial tenía 54,623 acciones de Ligand Pharmaceuticals con un valor de USD 17.3 M.
- Prudential Financial vendió 9,510 acciones de Ligand Pharmaceuticals en T2 2026, por un valor estimado de USD 2.24 M.
- Ligand Pharmaceuticals representó 0.02% de la cartera de Prudential Financial en T2 2026 y fue su posición número 482.
- Prudential Financial reportó por primera vez una posición en Ligand Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Prudential Financial en Ligand Pharmaceuticals alcanzó su máximo de USD 29.3 M en T3 2018.
- Al cierre de T2 2026, 418 fondos que sigue Wall St. Rank tenían Ligand Pharmaceuticals en cartera.
Según el Informe 13F de Prudential Financial correspondiente a T2 2026, presentado el 12 ago 2026.